Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$501M |
| 2 |
AbbVie
ABBV
|
+$381M |
| 3 |
Eli Lilly
LLY
|
+$377M |
| 4 |
Adobe
ADBE
|
+$368M |
| 5 |
Qualcomm
QCOM
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.38B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.03B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$589M |
| 4 |
Tesla
TSLA
|
+$536M |
| 5 |
Stellantis
STLA
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.88% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Financials | 10.3% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IAS
1626
DELISTED
Integral Ad Science
IAS
| $97.4K | ﹤0.01% |
6,620
-3,138
| -32% | -$35.2K |
|
|
JKS
1627
JinkoSolar
JKS
$775M
| $97.4K | ﹤0.01% |
2,036
-1,300
| -39% | -$68.1K |
|
1628
Usana Health Sciences
USNA
$394M
| $97K | ﹤0.01% |
1,516
-7,074
| -82% | -$422K |
|
1629
Varex Imaging
VREX
$460M
| $97K | ﹤0.01% |
+5,430
| New | +$103K |
|
|
CCC
1630
CCC Intelligent Solutions
CCC
$3.42B
| $96.6K | ﹤0.01% |
11,098
-1,468
| -12% | -$13.1K |
|
1631
Heartland Express
HTLD
$1.11B
| $96.3K | ﹤0.01% |
+6,338
| New | +$103K |
|
|
ETRN
1632
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $95.8K | ﹤0.01% |
+19,400
| New | +$124K |
|
1633
Columbia Sportswear
COLM
$3.19B
| $95.6K | ﹤0.01% |
1,068
| – | – |
|
1634
Vanguard S&P 500 Value ETF
VOOV
$6.58B
| $95.3K | ﹤0.01% |
655
| – | – |
|
1635
HighPeak Energy
HPK
$967M
| $95K | ﹤0.01% |
3,964
-85
| -2% | -$2.16K |
|
1636
PC Connection
CNXN
$2.05B
| $94.1K | ﹤0.01% |
+2,096
| New | +$95.6K |
|
1637
StoneCo
STNE
$2.62B
| $93.3K | ﹤0.01% |
10,407
-3,618
| -26% | -$34.6K |
|
1638
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
| $93.2K | ﹤0.01% |
2,430
| – | – |
|
1639
Regenxbio
RGNX
$623M
| $93.1K | ﹤0.01% |
+5,126
| New | +$113K |
|
1640
Travel + Leisure Co
TNL
$4.54B
| $92.6K | ﹤0.01% |
2,452
| – | – |
|
1641
Mesa Laboratories
MLAB
$539M
| $92.4K | ﹤0.01% |
542
| – | – |
|
1642
Vicor
VICR
$9.62B
| $92.4K | ﹤0.01% |
2,045
+247
| +14% | +$13.7K |
|
|
OSG
1643
Octave Specialty Group
OSG
$252M
| $91.9K | ﹤0.01% |
+6,120
| New | +$99K |
|
1644
Safety Insurance
SAFT
$1.52B
| $91.6K | ﹤0.01% |
+1,200
| New | +$97.8K |
|
|
HAYN
1645
DELISTED
Haynes International, Inc.
HAYN
| $91.6K | ﹤0.01% |
+1,955
| New | +$103K |
|
1646
Standard Motor Products
SMP
$861M
| $91.5K | ﹤0.01% |
+2,554
| New | +$97.2K |
|
1647
BJ's Restaurants
BJRI
$1.41B
| $91.4K | ﹤0.01% |
+3,193
| New | +$99.6K |
|
|
OLPX
1648
DELISTED
Olaplex Holdings
OLPX
| $91.1K | ﹤0.01% |
22,500
-14,034
| -38% | -$74.8K |
|
1649
Kornit Digital
KRNT
$706M
| $90.7K | ﹤0.01% |
5,084
| – | – |
|
1650
Surgery Partners
SGRY
$2.06B
| $90.7K | ﹤0.01% |
2,611
| – | – |
|
Similar funds
Amundi's Q1 2023 Portfolio in Review
As of Q1 2023, Amundi held 2,154 positions worth $186B, up 1.8% from $182B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amundi's Q1 2023 filing shows 278 new, 828 increased, 617 reduced and 102 closed positions. Its largest new stake was GE HealthCare: 514,041 shares worth $41.7M. The largest sale was Linde, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q1 2023 buy was GE HealthCare: 514,041 shares worth $41.7M.
- Amundi added most to Intel in Q1 2023, an estimated $501M increase.
- Amundi's biggest Q1 2023 reduction was Linde, cutting an estimated $1.38B.
- Amundi fully exited SVB Financial Group in Q1 2023, selling an estimated $59.9M.
- Amundi's ten largest holdings make up 20% of its $186B portfolio in Q1 2023.
- Amundi opened 278 new positions and closed 102 in Q1 2023.
- Amundi's portfolio value rose 1.8% quarter-over-quarter to $186B.
Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.